*Result*: Recurrence Score® result impacts treatment decisions in hormone receptor-positive, HER2-negative patients with early breast cancer in a real-world setting - results of the IRMA trial
*Author/editor-in-chief*:
Dannehl, Dominik (Verfasser); Engler, Tobias (Verfasser); Volmer, Lea L. (Verfasser); Staebler, Annette (Verfasser); Fischer, Anna K. (Verfasser); Weiss, Martin (Verfasser); Hahn, Markus (Verfasser); Walter, Christina B. (Verfasser); Grischke, Eva-Maria (Verfasser) ; Fend, Falko (Verfasser) ; Ţăran, Florin-Andrei (Verfasser) ; Brucker, Sara (Verfasser) ; Hartkopf, Andreas D. (Verfasser)
*Publication*:
Freiburg : Universität, 2022
*Physical description scale*:
1 Online-Ressource
*Format*:
*Language*:
*eng*
*Notes*:
Cancers. - 14, 21 (2022) , 5365, ISSN: 2072-6694
*DOI*:
10.3390/cancers14215365